P08684 (CP3A4_HUMAN) Homo sapiens (Human)

Cytochrome P450 3A4 UniProtKBInterProSTRINGInteractive Modelling

503 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: Q6GRK0

Available Structures

100 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human CYP3A4 bound to a suicide substrate
6oob
homo-4-mer26-496
4×HEM; 4×MWS;
Assess
Human CYP3A4 bound to a drug mibefradil
6oo9
homo-4-mer26-496
4×HEM; 4×MWV; 8×EDO; 4×DMS;
Assess
Crystal structure of human CYP3A4 bound to an inhibitor
6bdk
homo-4-mer27-497
4×HEM; 4×DJ1;
Assess
Crystal structure of human CYP3A4 bound to an inhibitor
6bcz
homo-4-mer27-496
4×HEM; 4×D7Y;
Assess
Crystal structure of human CYP3A4 bound to an inhibitor
6bd6
homo-4-mer28-496
4×HEM; 4×80K;
Assess
Human CYP3A4 bound to a drug substrate
6ooa
homo-4-mer28-496
4×HEM; 4×GOL; 4×MWY;
Assess
Crystal structure of human CYP3A4 bound to an inhibitor
6bd5
homo-4-mer29-496
4×HEM; 4×D7M;
Assess
Crystal structure of the midazolam-bound human CYP3A4
5te8
homo-3-mer22-497
3×HEM; 3×08J;
Assess
Human CYP3A4 bound to PMSF
6ma8
homo-2-mer26-497
2×HEM; 4×GOL; 2×PMF; 14×EDO; 2×DMS;
Assess
Human CYP3A4 bound to an inhibitor fluconazole
6ma7
homo-2-mer26-497
2×HEM; 2×TPF; 2×DMS; 2×EDO;
Assess
Human CYP3A4 bound to a substrate
8so2
homo-2-mer26-497
2×HEM; 12×CFF;
Assess
Human CYP3A4 bound to an inhibitor metyrapone
6ma6
homo-2-mer26-497
2×HEM; 2×GOL; 2×MYT; 2×EDO;
Assess
Human CYP3A4 bound to a substrate
8dyc
homo-2-mer26-497
2×HEM; 2×UC7; 2×GOL;
Assess
Crystal structure of the cysteine depleted CYP3A4 bound to glycerol
5vcd
homo-2-mer26-496
2×HEM; 24×GOL;
Assess
Human CYP3A4 bound to three caffeine molecules
8so1
homo-2-mer26-496
2×HEM; 6×CFF;
Assess
Crystal structure of CYP3A4 bound to an inhibitor
8ews
homo-2-mer27-497
2×HEM; 2×X2Q;
Assess
Crystal structure of the cysteine depleted CYP3A4 bound to ritonavir
5vce
homo-2-mer26-496
2×HEM; 2×RIT;
Assess
Crystal structure of CYP3A4 bound to an inhibitor
8ewq
homo-2-mer26-496
2×HEM; 2×X2B;
Assess
CYP3A4 bound to an inhibitor
7ufb
homo-2-mer27-497
2×HEM; 2×NJ0;
Assess
Crystal structure of CYP3A4 bound to an inhibitor
8ewe
homo-2-mer26-496
2×HEM; 2×X0E;
Assess
Crystal structure of CYP3A4 bound to an inhibitor
8ewm
homo-2-mer27-497
2×HEM; 2×X1I;
Assess
Human CYP3A4 bound to an inhibitor
7ufe
homo-2-mer26-496
2×HEM; 3×GOL; 2×NXR;
Assess
Crystal structure of human CYP3A4 bound to an inhibitor
6bdi
homo-2-mer27-497
2×HEM; 2×DEJ;
Assess
Human CYP3A4 bound to an inhibitor
6unh
homo-2-mer27-497
2×HEM; 2×QEA;
Assess
Crystal structure of the cysteine depleted CYP3A4 bound to bromoergocryptine
5vcg
homo-2-mer28-497
2×HEM; 2×08Y; 8×GOL;
Assess
Human CYP3A4 bound to an inhibitor
7ufc
homo-2-mer27-496
2×HEM; 2×NJO;
Assess
Crystal structure of CYP3A4 bound to an inhibitor
8ewl
homo-2-mer27-496
2×HEM; 2×X1C;
Assess
Crystal structure of CYP3A4 bound to an inhibitor
8ewp
homo-2-mer27-496
2×HEM; 2×X2Q;
Assess
Crystal structure of human CYP3A4 bound to an inhibitor
6bd7
homo-2-mer28-497
2×HEM; 2×D7J;
Assess
CYP3A4 bound to an inhibitor
7uf9
homo-2-mer27-496
2×HEM; 2×NH0;
Assess
CYP3A4 bound to an inhibitor
7ufa
homo-2-mer28-497
2×HEM; 2×NI6;
Assess
Crystal structure of human CYP3A4 with the caged inhibitor
7ks8
homo-2-mer28-497
2×HEM; 2×GOL; 2×X8S;
Assess
CYP3A4 bound to an inhibitor
6unl
homo-2-mer27-496
2×HEM; 2×QDJ;
Assess
Human CYP3A4 bound to an inhibitor
7kvk
homo-2-mer27-496
2×HEM; 2×X7J; 2×SO4; 2×GOL; 1×EDO;
Assess
Crystal structure of human CYP3A4 bound to metformin
5g5j
homo-2-mer28-497
2×MF8; 2×HEM;
Assess
Human CYP3A4 bound to an inhibitor
6uni
homo-2-mer27-496
2×HEM; 2×QDV;
Assess
Human CYP3A4 bound to an inhibitor
6unk
homo-2-mer27-496
2×HEM; 2×QE4;
Assess
Human CYP3A4 bound to an inhibitor
7ufd
homo-2-mer27-496
2×HEM; 2×T0K;
Assess
Crystal structure of CYP3A4 bound to an inhibitor
8ewn
homo-2-mer28-496
2×HEM; 2×X1O;
Assess
Crystal structure of human CYP3A4 bound to an inhibitor
6bdh
homo-2-mer28-496
2×HEM; 2×DEV;
Assess
Human CYP3A4 bound to an inhibitor
6ung
homo-2-mer28-496
2×HEM; 2×QEP;
Assess
Crystal structure of human CYP3A4 with the caged inhibitor
7ksa
homo-2-mer28-496
2×HEM; 2×X8P;
Assess
Human CYP3A4 bound to an inhibitor
7kvs
homo-2-mer28-496
2×HEM; 1×SO4; 2×GOL; 2×EDO; 2×X74;
Assess
Human CYP3A4 bound to an inhibitor
7kvi
homo-2-mer28-496
2×HEM; 2×GOL; 2×X7P;
Assess
Crystal structure of human CYP3A4 bound to an inhibitor
6bdm
homo-2-mer28-496
2×HEM; 2×Y83;
Assess
Crystal structure of human CYP3A4 with the caged inhibitor
7uaz
homo-2-mer28-496
2×HEM; 2×O3L;
Assess
Human CYP3A4 bound to an inhibitor
7kvj
homo-2-mer28-496
2×HEM; 2×X7M;
Assess
Crystal structure of human CYP3A4 bound to ritonavir
5vc0
homo-2-mer28-496
2×HEM; 2×RIT;
Assess
Human CYP3A4 bound to an inhibitor
7kvp
homo-2-mer29-497
2×HEM; 2×X6J;
Assess
Crystal structure of human CYP3A4 bound to the testosterone dimer
7lxl
homo-2-mer28-496
2×HEM; 2×YNV;
Assess
Human CYP3A4 bound to an inhibitor
7kvm
homo-2-mer28-496
2×HEM; 2×X71;
Assess
Crystal structure of human CYP3A4 bound to glycerol
5vcc
homo-2-mer29-496
2×HEM; 16×GOL; 24×EDO;
Assess
Crystal structure of CYP3A4 bound to an inhibitor
8exb
homo-2-mer29-496
2×HEM; 2×X4E;
Assess
Crystal structure of CYP3A4 bound to an inhibitor
8ewr
homo-2-mer29-496
2×HEM; 2×WZN;
Assess
Crystal structure of CYP3A4 bound to an inhibitor
8ewd
homo-2-mer29-496
2×HEM; 2×WZN;
Assess
Crystal structure of human CYP3A4 bound to an inhibitor
6bd8
homo-2-mer29-496
2×HEM; 2×D81;
Assess
Human CYP3A4 bound to an inhibitor
6une
homo-2-mer29-496
2×HEM; 2×QES;
Assess
Human CYP3A4 bound to an inhibitor
6unj
homo-2-mer29-496
2×HEM; 2×QDY;
Assess
Human CYP3A4 bound to an inhibitor
7kvo
homo-2-mer29-496
2×HEM; 1×SO4; 2×X6S;
Assess
Human CYP3A4 bound to an inhibitor
7kvn
homo-2-mer29-496
2×HEM; 2×X6V;
Assess
Human CYP3A4 bound to an inhibitor
7uff
homo-2-mer29-496
2×HEM; 1×PO4; 2×NYF;
Assess
Human CYP3A4 bound to an inhibitor
7kvq
homo-2-mer29-496
2×HEM; 1×SO4; 1×GOL; 3×EDO; 2×X7D;
Assess
Crystal structure of human CYP3A4 with the caged inhibitor
7uay
homo-2-mer29-496
2×HEM; 2×O39;
Assess
Human CYP3A4 bound to an inhibitor
7kvh
homo-2-mer29-496
2×HEM; 2×X5Y;
Assess
CYP3A4 bound to an inhibitor
6unm
homo-2-mer29-495
2×HEM;
Assess
Crystal structure of human cytochrome P450 3A4
1w0e
monomer25-499
1×HEM;
Assess
Crystal structure of human cytochrome P450 3A4
1w0f
monomer25-498
1×STR; 1×HEM;
Assess
Crystal structure of human cytochrome P450 3A4
1w0g
monomer25-498
1×MYT; 1×HEM;
Assess
Crystal Structure of Human Microsomal P450 3A4
1tqn
monomer28-499
1×HEM;
Assess
Crystal structure of cytochrome P450 3A4 bound to progesterone
5a1r
monomer26-497
1×STR; 1×HEM;
Assess
Crystal structure of cytochrome P450 3A4 bound to progesterone and citrate
5a1p
monomer26-497
1×HEM; 1×STR; 1×CIT;
Assess
Cytochrome P450 3A4 bound to an inhibitor
4d78
monomer27-497
1×HEM; 1×J9K; 2×GOL;
Assess
Crystal structure of CYP3A4 in complex with an inhibitor
4ny4
monomer28-498
1×HEM; 1×2QH;
Assess
Human CYP3A4 bound to an inhibitor
6daa
monomer27-496
1×HEM; 1×G0M;
Assess
Human CYP3A4 bound to an inhibitor
6da5
monomer27-496
1×HEM; 1×G1J;
Assess
Human CYP3A4 bound to an inhibitor
6da3
monomer27-496
1×HEM; 1×G0D;
Assess
Human CYP3A4 bound to an inhibitor
6dac
monomer27-496
1×HEM; 1×FZV;
Assess
Crystal structure of human CYP3A4 coordinated to a water molecule
4i3q
monomer28-497
1×HEM;
Assess
Human CYP3A4 bound to an inhibitor
6dal
monomer27-496
1×HEM; 1×GOL; 1×G1D;
Assess
Crystal structure of CYP3A4 ligated to oxazole-substituted desoxyritonavir
4i4g
monomer27-496
1×HEM; 1×Z8Z;
Assess
Human CYP3A4 bound to an inhibitor
6dag
monomer27-496
1×HEM; 1×G0Y;
Assess
Human CYP3A4 bound to an inhibitor
6da8
monomer27-496
1×HEM; 1×G0J;
Assess
Complex of human CYP3A4 with a desoxyritonavir analog
4k9u
monomer27-496
1×HEM; 2×5AW;
Assess
Cytochrome P450 3A4 bound to imidazole and an inhibitor
4d6z
monomer29-497
1×HEM; 1×PK9; 1×IMD; 4×GOL;
Assess
Crystal structure of the cytochrome P4503A4-bromoergocryptine complex
3ua1
monomer28-496
1×HEM; 1×08Y;
Assess
Cytochrome P450 3A4 bound to an inhibitor
4d75
monomer28-496
1×PK9; 1×HEM;
Assess
Human CYP3A4 bound to an inhibitor
6daj
monomer28-496
1×HEM; 1×FZV; 1×GOL; 1×GLN;
Assess
Complex of CYP3A4 with a desoxyritonavir analog
4k9t
monomer29-497
1×HEM; 2×1RD;
Assess
Complex of CYP3A4 with a desoxyritonavir analog
4k9v
monomer28-496
1×HEM; 1×6AW;
Assess
Human CYP3A4 bound to an inhibitor
6da2
monomer28-496
1×HEM; 1×GOL; 1×G0D;
Assess
Cytochrome P450 3A4 bound to an inhibitor
4d7d
monomer29-497
1×HEM; 1×PKT;
Assess
Crystal structure of human P450 3A4 in complex with ketoconazole
2v0m
monomer30-498
1×HEM; 2×KLN;
Assess
Cytochrome P450 (CYP) 3A4 crystallized with clotrimazole
8spd
monomer28-496
1×HEM; 1×CL6;
Assess
Crystal structure of human cytochrome P4503A4 bound to an inhibitor ritonavir
3nxu
monomer29-496
4×DMS; 1×HEM; 1×RIT;
Assess
Crystal Structure of the complex between human cytochrome P450 3A4 and desthiazolylmethyloxycarbony…
3tjs
monomer29-496
1×HEM; 1×D0R;
Assess
Human CYP3A4 bound to an inhibitor
6dab
monomer29-496
1×HEM; 1×GOL; 1×G0V;
Assess
Complex of human CYP3A4 with a desoxyritonavir analog
4k9w
monomer29-496
1×HEM; 1×7AW;
Assess
Crystal structure of human P450 3A4 in complex with erythromycin
2j0d
monomer29-496
1×HEM; 1×ERY;
Assess
Complex of human CYP3A4 with a desoxyritonavir analog
4k9x
monomer29-496
1×HEM; 1×8AW;
Assess
Crystal structure of CYP3A4 ligated to pyridine-substituted desoxyritonavir
4i4h
monomer29-496
1×HEM; 1×Z9Z;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8so1.1.Bhomo-2-mer0.8726-496
2×HEM; 6×CFF;100.00
Assess